Biotech News
KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026
ir.kalvista.com2026-05-06 15:26 EST
FRAMINGHAM, Mass. & SALISBURY, England --(BUSINESS WIRE)--Mar. 18, 2026-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) will host a conference call and webcast on Wednesday, March 25, 2026, at 8:30 a.m. ET to review the Company’s eight months fiscal year 2025 financial results and provide a